Rahbari, M., Pecqueux, M., Aust, D., Stephan, H., Tiebel, O., Chatzigeorgiou, A., . . . Kahlert, C. (2019). Expression of Glypican 3 Is an Independent Prognostic Biomarker in Primary Gastro-Esophageal Adenocarcinoma and Corresponding Serum Exosomes. Journal of Clinical Medicine, 8(5), 696. https://doi.org/10.3390/jcm8050696
Chicago Style (17th ed.) CitationRahbari, Mohammad, et al. "Expression of Glypican 3 Is an Independent Prognostic Biomarker in Primary Gastro-Esophageal Adenocarcinoma and Corresponding Serum Exosomes." Journal of Clinical Medicine 8, no. 5 (2019): 696. https://doi.org/10.3390/jcm8050696.
MLA (9th ed.) CitationRahbari, Mohammad, et al. "Expression of Glypican 3 Is an Independent Prognostic Biomarker in Primary Gastro-Esophageal Adenocarcinoma and Corresponding Serum Exosomes." Journal of Clinical Medicine, vol. 8, no. 5, 2019, p. 696, https://doi.org/10.3390/jcm8050696.